Adenosine A3 receptors: novel ligands and paradoxical effects.
about
Adenosine receptors as therapeutic targetsPain and Poppies: The Good, the Bad, and the Ugly of Opioid AnalgesicsThe plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cellsPharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cellsA1 adenosine receptors inhibit multiple voltage-gated Ca2+ channel subtypes in acutely isolated rat basolateral amygdala neuronsCyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell lineNeoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosidesGrafts of adenosine-releasing cells suppress seizures in kindling epilepsyStructure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonistsAdenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeabilityPyran Template Approach to the Design of Novel A3 Adenosine Receptor AntagonistsAdenosine 2A receptors in acute kidney injuryAdenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.Adenosine-A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes.Dual purinergic synaptic transmission in the human enteric nervous system.Adenosine and ischemic preconditioning.Xanthines as adenosine receptor antagonists.A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulationAdenosine and neurotrauma: therapeutic perspectives.Renal microvascular effects of P2 receptor stimulation.Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 - 2014).Adenosine receptors and renal ischaemia reperfusion injury.Intracellular ATP concentration contributes to the cytotoxic and cytoprotective effects of adenosineBehavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure-activity relationshipsAdenosine receptor agonists: from basic medicinal chemistry to clinical development.Adenosine and protection from acute kidney injury.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsControlling murine and rat chronic pain through A3 adenosine receptor activationA3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptorsExploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure.Chapter 13. A3 Adenosine Receptors.Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.
P2860
Q24632095-2F74B45F-6D87-4348-9D14-920DCA144490Q26782928-A560F008-CB78-4123-8B4C-0C295C544BFCQ28346730-311B8252-DD92-4AD0-B27D-3FAA37ACD38FQ28346734-0C32A524-61D0-4F02-93F9-255DF8CB82A9Q28349832-B8EA5ABE-E59E-47CB-A578-F91F34C306A2Q28354178-8941F39C-876B-4262-B65B-5AA602D9A6FAQ28363730-D2C0737F-25AE-4CBA-93F5-D1EEC78BAEEDQ28364092-FF5EB721-C4F2-4A36-A7E3-1B3AB314DB4EQ28366761-9B36A461-A59A-4B99-9BBD-7A2AF44B7CDCQ28368377-BF44926F-27F0-49B7-89A9-C941FBC55AEBQ28565968-96D2B577-97DD-4D42-B46A-E2F77B46DC69Q28834245-7A4495F5-D3C0-486F-A718-5A237DF02BE6Q30300186-B52E1F17-C78E-4BC2-A393-5437DC71E088Q30413271-13A17AF8-5425-42C0-9BB6-9A42741EEBB1Q30431277-11835FDD-80AB-42BC-84F6-71DF7070A3F4Q30542407-581B217C-55FD-4129-9F93-98AF5684D393Q33310253-1C753B68-F4DF-44DF-8319-A06E2F2F41AFQ33801903-E02ACD48-8F53-41BA-ADE2-99BE6507773FQ34139398-DC29CB9B-67B3-44E6-8A30-F7F05594134DQ34159374-C47EB65B-BAA1-41ED-AC40-79FD65FB4CB0Q34230282-EC5A56BF-E438-4DAC-BBC7-850546E629F3Q34242547-1A9E1F01-A7B3-4BDF-A805-3771DBEB7357Q34457651-1B518FEF-5C20-4CE2-826F-B582CF54E4D1Q34735024-6F17BE57-6DFD-4661-9021-49F3853FB91DQ35009649-97BEB7B3-864B-40E8-9E32-6CCEC007AE12Q35133003-7E964759-6A4D-4896-AF24-69C6629F9C2CQ35235736-6B57129E-65EC-4CC1-A2FE-FFCB7C8A846AQ35545074-AB77DF81-C34A-4FCC-BBCF-C2768E22131DQ35602688-65A4B50A-D391-42BC-878F-0EBF581894B7Q35755490-A5E5D5CE-363A-4FEF-8851-0867D4F62852Q35788500-7A5064B2-A45D-4356-910B-55582308D502Q35913037-BD0DAC18-B322-4F13-BDD2-FEC94214AA24Q35928226-D4F912A5-AD6F-4261-A533-6EA4BF306C4CQ36025393-F884A2E4-79AB-4025-881A-DEF029047A4FQ36246984-A9F98FB5-A59F-4939-8352-FD155A808670Q36286344-84B1FD1B-ED95-4DBD-91C6-AEFB3D7E2D23Q36316924-7227C352-3C6F-488D-844E-9573058971B8Q36317172-085946D5-81EB-4A38-979D-EC3890437EAFQ36342540-56D143C3-F926-46DE-954E-945101DCF7D8Q36457546-F9B443D4-CC05-4EBF-8BDA-E0B07001D5C0
P2860
Adenosine A3 receptors: novel ligands and paradoxical effects.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Adenosine A3 receptors: novel ligands and paradoxical effects.
@ast
Adenosine A3 receptors: novel ligands and paradoxical effects.
@en
type
label
Adenosine A3 receptors: novel ligands and paradoxical effects.
@ast
Adenosine A3 receptors: novel ligands and paradoxical effects.
@en
prefLabel
Adenosine A3 receptors: novel ligands and paradoxical effects.
@ast
Adenosine A3 receptors: novel ligands and paradoxical effects.
@en
P2860
P1476
Adenosine A3 receptors: novel ligands and paradoxical effects.
@en
P2093
K A Jacobson
P2860
P304
P356
10.1016/S0165-6147(98)01203-6
P577
1998-05-01T00:00:00Z